Latest Market News

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTORITY, PUBLISHED IN APPLICATION OF ARTICLE 34, § 2, PARAGRAPH 3, OF THE LAW OF 2 AUGUST 2002 Trading in AGEAS (BE0003801181) on Euronext Brussels is suspended on request of the issuer on 23 March 2012 from 01:25 p.m., until the publication of a press release.   Source: […]

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 34, § 2, PARAGRAPH 3, OF THE LAW OF 2 AUGUST 2002 Trading in AGEAS (BE0003801181) on Euronext Brussels will re-open on March 23, 2012 at 15h30.   Source: FSMA

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 34, § 2, PARAGRAPH 3, OF THE LAW OF 2 AUGUST 2002 Trading in Softimat, ISIN code BE0003773877 on Euronext Brussels will re-open on  22/03/2012 at 08:30am.   Source: FSMA

The U.S.-listed shares of China-based companies surged in premarket trading Friday, after Bloomberg reported that Chinese authorities are in the process of giving U.S. regulators full access to auditing reports. That would allow China-based companies to remain listed on U.S. exchanges, removing an overhang that has weighed on the American depositary receipts (ADRs) of China-based […]

Shares of XPeng Inc. XPEV, +5.80% shot up 8.7% in premarket trading, boosted by the broad rally in the U.S.-listed shares of China-based companies and after the electric vehicle maker reported a tripling in March deliveries. The company said it delivered 15,414 EVs were delivered in March, up 202% from a year ago, and up […]

Merck MRK, +1.79% and privately held Ridgeback Biotherapeutics said Friday they will present data showing that treatment with their COVID-19 antiviral ended infectious illness more rapidly than placebo in a late-stage trial. Data on the treatment, called molnupiravir in the U.S., will be presented at the 2022 European Congress of Clinical Microbiology & Infectious Diseases, […]